Skip to main content
Premium Trial:

Request an Annual Quote

Invitrogen Partnering With Lentigen to Develop New Gene Expression Products

NEW YORK (GenomeWeb News) – Invitrogen announced today that it will work with Maryland-based biotechnology company Lentigen to develop and market products and services for gene over-expression based on Lentigen’s lentiviral gene delivery technology and Invitrogen’s human gene collections and cloning and gene synthesis technologies.
 
Invitrogen said that it will provide Lentigen with access to its human and mouse gene libraries, which will be used in conjunction with lentiviral gene delivery systems to create new gene expression systems for mammalian cells.
 
Any products or services developed within the partnership will be commercialized exclusively by Invitrogen. Further terms of the alliance were not disclosed.
 
“Researchers will be able to easily obtain ready-to-use lentiviral particles carrying either customer-designed genetic elements or predetermined and validated gene sets from Invitrogen’s Ultimate ORF collection,” Invitrogen Vice President of Cloning and Protein Expression Nathan Wood said in a statement.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.